{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:40:56Z","timestamp":1790959256454,"version":"4.1.0"},"reference-count":160,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jaad.2025.06.035","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T11:08:35Z","timestamp":1750331315000},"page":"937-952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Part I: Dermatologic manifestations in patients with kidney disease"],"prefix":"10.1016","volume":"95","author":[{"given":"Amit","family":"Singal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn E.","family":"Cowper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine J.","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Kroshinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry I.","family":"Lipner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Robinson-Bostom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"Yosipovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5913-9304","authenticated-orcid":false,"given":"Shari R.","family":"Lipner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jaad.2025.06.035_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","article-title":"Epidemiology of chronic kidney disease: an update 2022","volume":"12","author":"Kovesdy","year":"2022","journal-title":"Kidney Int Supplements"},{"key":"10.1016\/j.jaad.2025.06.035_bib2","series-title":"Chronic Kidney Disease in the United States","year":"2023"},{"issue":"11","key":"10.1016\/j.jaad.2025.06.035_bib3","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1097\/01.ASN.0000091586.46532.B4","article-title":"Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States","volume":"14","author":"Hsu","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.035_bib4","first-page":"86","article-title":"Cutaneous and mucosal manifestations in patients on maintenance hemodialysis: a study of 101 patients in Sari, Iran","volume":"2","author":"Hajheydari","year":"2008","journal-title":"Iran J Kidney Dis"},{"issue":"12","key":"10.1016\/j.jaad.2025.06.035_bib5","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1365-4362.1992.tb03543.x","article-title":"Cutaneous alterations in patients with chronic renal failure","volume":"31","author":"Pic\u00f3","year":"1992","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.035_bib6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jaad.2023.03.051","article-title":"A phase 2 study of oral difelikefalin in subjects with chronic kidney disease and moderate-to-severe pruritus","volume":"89","author":"Yosipovitch","year":"2023","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.035_bib7","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1912770","article-title":"A phase 3 trial of difelikefalin in hemodialysis patients with pruritus","volume":"382","author":"Fishbane","year":"2020","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jaad.2025.06.035_bib8","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s10157-021-02047-2","article-title":"Anti-pruritic effect of nemolizumab in hemodialysis patients with uremic pruritus: a phase II, randomized, double-blind, placebo-controlled clinical study","volume":"25","author":"Kinugasa","year":"2021","journal-title":"Clin Exp Nephrol"},{"issue":"12","key":"10.1016\/j.jaad.2025.06.035_bib9","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1093\/ndt\/gfl461","article-title":"Pruritus in haemodialysis patients: international results from the dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"21","author":"Pisoni","year":"2006","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"10.1016\/j.jaad.2025.06.035_bib10","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s11136-011-9964-x","article-title":"Assessment of the psychological burden associated with pruritus in hemodialysis patients using the kidney disease quality of life short form","volume":"21","author":"Lopes","year":"2012","journal-title":"Qual Life Res"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.035_bib11","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/hdi.12158","article-title":"Pruritus in hemodialysis patients: results from the Japanese Dialysis Outcomes and Practice Patterns Study (JDOPPS)","volume":"18","author":"Kimata","year":"2014","journal-title":"Hemodial Int"},{"issue":"5","key":"10.1016\/j.jaad.2025.06.035_bib12","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2215\/CJN.09600818","article-title":"Pruritus and patient reported outcomes in non-dialysis CKD","volume":"14","author":"Sukul","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.jaad.2025.06.035_bib13","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1007\/s11136-023-03438-6","article-title":"Chronic kidney disease-associated pruritus (CKD-aP) is associated with worse quality of life and increased healthcare utilization among dialysis patients","volume":"32","author":"Titapiccolo","year":"2023","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jaad.2025.06.035_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/IJNRD.S108045","article-title":"Chronic kidney disease-associated pruritus: impact on quality of life and current management challenges","volume":"10","author":"Shirazian","year":"2017","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"12","key":"10.1016\/j.jaad.2025.06.035_bib15","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.2215\/CJN.03280317","article-title":"International comparisons of prevalence, awareness, and treatment of pruritus in people on hemodialysis","volume":"12","author":"Rayner","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl 3","key":"10.1016\/j.jaad.2025.06.035_bib16","doi-asserted-by":"crossref","first-page":"i16","DOI":"10.1093\/ckj\/sfab167","article-title":"Clinical management of chronic kidney disease-associated pruritus: current treatment options and future approaches","volume":"14","author":"Lipman","year":"2021","journal-title":"Clin Kidney J"},{"issue":"Suppl 3","key":"10.1016\/j.jaad.2025.06.035_bib17","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1093\/ckj\/sfab142","article-title":"Epidemiology and burden of chronic kidney disease-associated pruritus","volume":"14","author":"Kim","year":"2021","journal-title":"Clin Kidney J"},{"issue":"4","key":"10.1016\/j.jaad.2025.06.035_bib18","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s11255-015-1208-5","article-title":"Epidemiology and determinants of pruritus in pre-dialysis chronic kidney disease patients","volume":"48","author":"Solak","year":"2016","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.035_bib19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2215\/CJN.09480822","article-title":"Incidence and risk factors for pruritus in patients with nondialysis CKD","volume":"18","author":"Wulczyn","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.jaad.2025.06.035_bib20","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDe2300227","article-title":"Chronic kidney disease-associated pruritus, still a vexing problem","volume":"2","author":"Yosipovitch","year":"2023","journal-title":"NEJM Evid"},{"issue":"21","key":"10.1016\/j.jaad.2025.06.035_bib21","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000010633","article-title":"Prevalence of chronic kidney disease-associated pruritus among adult dialysis patients: a meta-analysis of cross-sectional studies","volume":"97","author":"Hu","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.035_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2023.100754","article-title":"CKD-associated pruritus and clinical outcomes in nondialysis CKD","volume":"6","author":"Scherer","year":"2024","journal-title":"Kidney Med"},{"issue":"11","key":"10.1016\/j.jaad.2025.06.035_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2024.100900","article-title":"Chronic kidney disease-associated pruritus burden: a patient survey study","volume":"6","author":"Thompson","year":"2024","journal-title":"Kidney Med"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.035_bib24","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1365-2133.2009.09088.x","article-title":"Depressive symptoms predict the future risk of severe pruritus in haemodialysis patients: Japan Dialysis Outcomes and Practice Patterns Study","volume":"161","author":"Yamamoto","year":"2009","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.035_bib25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.xkme.2020.08.011","article-title":"Self-reported pruritus and clinical, dialysis-related, and patient-reported outcomes in hemodialysis patients","volume":"3","author":"Sukul","year":"2021","journal-title":"Kidney Med"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.035_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2023.100635","article-title":"Burden of pruritus in advanced CKD and hemodialysis: results from National Kidney Foundation surveys","volume":"5","author":"Lee","year":"2023","journal-title":"Kidney Med"},{"issue":"4","key":"10.1016\/j.jaad.2025.06.035_bib27","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/ki.2013.454","article-title":"Uremic pruritus","volume":"87","author":"Mettang","year":"2015","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.jaad.2025.06.035_bib28","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.2215\/CJN.00100110","article-title":"A longitudinal study of uremic pruritus in hemodialysis patients","volume":"5","author":"Mathur","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.035_bib29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/archderm.1982.01650150016012","article-title":"Clinical features of pruritus among patients undergoing maintenance hemodialysis","volume":"118","author":"Gilchrest","year":"1982","journal-title":"Arch Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2025.06.035_bib30","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.ekir.2020.04.027","article-title":"CKD-associated pruritus: new insights into diagnosis, pathogenesis, and management","volume":"5","author":"Verduzco","year":"2020","journal-title":"Kidney Int Rep"},{"issue":"4","key":"10.1016\/j.jaad.2025.06.035_bib31","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.semnephrol.2015.06.009","article-title":"Pruritus in kidney disease","volume":"35","author":"Combs","year":"2015","journal-title":"Semin Nephrol"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.035_bib32","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1053\/j.ajkd.2023.04.008","article-title":"Pruritus in hemodialysis patients: longitudinal associations with clinical and patient-reported outcomes","volume":"82","author":"Sukul","year":"2023","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.jaad.2025.06.035_bib33","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1093\/ndt\/gfh480","article-title":"Uraemic xerosis","volume":"19","author":"Szepietowski","year":"2004","journal-title":"Nephrol Dial Transpl"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.035_bib34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0885-3924(00)00256-6","article-title":"Understanding pruritus in systemic disease","volume":"21","author":"Krajnik","year":"2001","journal-title":"J Pain Symptom Manage"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.035_bib35","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.clindermatol.2019.07.031","article-title":"Pruritus as a sign of systemic disease","volume":"37","author":"Welz-Kubiak","year":"2019","journal-title":"Clin Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2025.06.035_bib36","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1590-8658(00)80847-6","article-title":"Pruritus in patients with chronic human immunodeficiency virus, hepatitis B and C virus infections","volume":"32","author":"Bonacini","year":"2000","journal-title":"Dig Liver Dis"},{"issue":"47","key":"10.1016\/j.jaad.2025.06.035_bib37","doi-asserted-by":"crossref","first-page":"17877","DOI":"10.3748\/wjg.v20.i47.17877","article-title":"Study of pruritus in chronic hepatitis C patients","volume":"20","author":"Suzuki","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.035_bib38","doi-asserted-by":"crossref","first-page":"E252","DOI":"10.1111\/hepr.12978","article-title":"Prevalence of pruritus in patients with chronic liver disease: a multicenter study","volume":"48","author":"Oeda","year":"2018","journal-title":"Hepatol Res"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.035_bib39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/bjd.16117","article-title":"British Association of Dermatologists' guidelines for the investigation and management of generalized pruritus in adults without an underlying dermatosis, 2018","volume":"178","author":"Millington","year":"2018","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.035_bib40","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ajh.22215","article-title":"Pruritus in primary myelofibrosis: clinical and laboratory correlates","volume":"87","author":"Vaa","year":"2012","journal-title":"Am J Hematol"},{"issue":"10","key":"10.1016\/j.jaad.2025.06.035_bib41","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1002\/1097-0142(19830515)51:10<1934::AID-CNCR2820511030>3.0.CO;2-R","article-title":"Severe pruritus should be a B-symptom in Hodgkin's disease","volume":"51","author":"Gobbi","year":"1983","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.jaad.2025.06.035_bib42","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2340\/00015555-3164","article-title":"European S2k guideline on chronic pruritus","volume":"99","author":"Weisshaar","year":"2019","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.035_bib43","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jpainsymman.2012.01.012","article-title":"Prevalence and severity of pruritus and quality of life in patients with cutaneous T-cell lymphoma","volume":"45","author":"Wright","year":"2013","journal-title":"J Pain Symptom Manage"},{"issue":"8","key":"10.1016\/j.jaad.2025.06.035_bib44","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1365-4632.2011.05188.x","article-title":"Prevalence and severity of pruritus in cutaneous T cell lymphoma","volume":"51","author":"Vij","year":"2012","journal-title":"Int J Dermatol"},{"issue":"14","key":"10.1016\/j.jaad.2025.06.035_bib45","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1001\/jama.1978.03280410036008","article-title":"Iron-deficiency pruritus","volume":"239","author":"Takkunen","year":"1978","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.035_bib46","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5812\/nephropathol.9873","article-title":"Dermatological diseases in patients with chronic kidney disease","volume":"2","author":"Gagnon","year":"2013","journal-title":"J Nephropathol"},{"issue":"12","key":"10.1016\/j.jaad.2025.06.035_bib47","first-page":"1332","article-title":"Itch in adult population with type 2 diabetes mellitus: clinical profile, pathogenesis and disease-related burden in a cross-sectional study","volume":"10","author":"Stefaniak","year":"2021","journal-title":"Biology (Basel)"},{"issue":"8","key":"10.1016\/j.jaad.2025.06.035_bib48","first-page":"1347","article-title":"Management of common opioid-induced adverse effects","volume":"74","author":"Swegle","year":"2006","journal-title":"Am Fam Physician"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.035_bib49","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2340\/00015555-0650","article-title":"Drug-induced pruritus: a review","volume":"89","author":"Reich","year":"2009","journal-title":"Acta Derm Venereol"},{"issue":"8","key":"10.1016\/j.jaad.2025.06.035_bib50","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1111\/jdv.16151","article-title":"Generalized chronic itch induced by small-fibre neuropathy: clinical profile and proposed diagnostic criteria","volume":"34","author":"Pereira","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.035_bib51","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jaad.2014.10.034","article-title":"Pruritus: an underrecognized symptom of small-fiber neuropathies","volume":"72","author":"Brenaut","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.035_bib52","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/jdv.18561","article-title":"Chronic pruritus in multiple sclerosis and clinical correlates","volume":"37","author":"Ingrasci","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.jaad.2025.06.035_bib53","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jaad.2013.12.015","article-title":"Chronic pruritus in HIV-positive patients in the southeastern United States: its prevalence and effect on quality of life","volume":"70","author":"Kaushik","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.035_bib54","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-051694","article-title":"Prevalence and risk factors of senile pruritus: a systematic review and meta-analysis","volume":"12","author":"Chen","year":"2022","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.jaad.2025.06.035_bib55","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1038\/sj.ki.5000251","article-title":"Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients","volume":"69","author":"Narita","year":"2006","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.035_bib56","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jocd.2012.11.012","article-title":"Secondary and tertiary hyperparathyroidism","volume":"16","author":"Jamal","year":"2013","journal-title":"J Clin Densitom"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.035_bib57","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1053\/j.ajkd.2019.07.013","article-title":"Symptoms of secondary hyperparathyroidism in patients receiving maintenance hemodialysis: a prospective cohort study","volume":"75","author":"Levy","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.jaad.2025.06.035_bib58","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1053\/j.ajkd.2017.05.018","article-title":"Treatment of uremic pruritus: a systematic review","volume":"70","author":"Simonsen","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.035_bib59","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/ckj\/sfz195","article-title":"Kt\/V: achievement, predictors and relationship to mortality in hemodialysis patients in the Gulf Cooperation Council countries: results from DOPPS (2012-18)","volume":"14","author":"AlSahow","year":"2021","journal-title":"Clin Kidney J"},{"issue":"8","key":"10.1016\/j.jaad.2025.06.035_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071404","article-title":"Uremic pruritus, dialysis adequacy, and metabolic profiles in hemodialysis patients: a prospective 5-year cohort study","volume":"8","author":"Ko","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.035_bib61","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1365-2230.2008.03075.x","article-title":"A randomized controlled trial of high-permeability haemodialysis against conventional haemodialysis in the treatment of uraemic pruritus","volume":"34","author":"Chen","year":"2009","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2025.06.035_bib62","doi-asserted-by":"crossref","first-page":"748","DOI":"10.2215\/CJN.05490610","article-title":"Randomized, double-blind study with glycerol and paraffin in uremic xerosis","volume":"6","author":"Balaskas","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.035_bib63","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/09546630802441218","article-title":"A pramoxine-based anti-itch lotion is more effective than a control lotion for the treatment of uremic pruritus in adult hemodialysis patients","volume":"20","author":"Young","year":"2009","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"10.1016\/j.jaad.2025.06.035_bib64","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/ndt\/gfp588","article-title":"Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study","volume":"25","author":"Kumagai","year":"2010","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.035_bib65","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1053\/j.ajkd.2009.04.014","article-title":"Treatment of pregabalin toxicity by hemodialysis in a patient with kidney failure","volume":"54","author":"Yoo","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1016\/j.jaad.2025.06.035_bib66","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1089\/jpm.2012.0504","article-title":"Use of sertraline for antihistamine-refractory uremic pruritus in renal palliative care patients","volume":"16","author":"Chan","year":"2013","journal-title":"J Palliat Med"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.035_bib67","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/hdi.12540","article-title":"Sertraline can reduce uremic pruritus in hemodialysis patient: a double blind randomized clinical trial from Southern Iran","volume":"22","author":"Pakfetrat","year":"2018","journal-title":"Hemodial Int"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.035_bib68","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jaad.2004.12.052","article-title":"Treatment of uremic pruritus with narrowband ultraviolet B phototherapy: an open pilot study","volume":"53","author":"Ada","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.035_bib69","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJM197707212970304","article-title":"Relief of uremic pruritus with ultraviolet phototherapy","volume":"297","author":"Gilchrest","year":"1977","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jaad.2025.06.035_bib70","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-4632.2004.02186.x","article-title":"UVB phototherapy and skin cancer risk: a review of the literature","volume":"44","author":"Lee","year":"2005","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2025.06.035_bib71","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/IJNRD.S145720","article-title":"Post-marketing surveillance study of the safety and efficacy of nalfurafine hydrochloride (Remitch(\u00ae) capsules 2.5 \u03bcg) in 3,762 hemodialysis patients with intractable pruritus","volume":"11","author":"Kozono","year":"2018","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"10","key":"10.1016\/j.jaad.2025.06.035_bib72","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae274","article-title":"Chronic kidney disease-associated pruritus and quality of life with difelikefalin treatment: a post hoc analysis of phase 3 data using the Skindex-10 questionnaire","volume":"17","author":"St\u00e4nder","year":"2024","journal-title":"Clin Kidney J"},{"issue":"4","key":"10.1016\/j.jaad.2025.06.035_bib73","first-page":"316","article-title":"Comparison of Avena sativa, vinegar, and hydroxyzine for uremic pruritus of hemodialysis patients: a crossover randomized clinical trial","volume":"9","author":"Nakhaee","year":"2015","journal-title":"Iran J Kidney Dis"},{"issue":"5","key":"10.1016\/j.jaad.2025.06.035_bib74","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.0906-6705.2004.00184.x","article-title":"Antipruritic effects of two different 5-HT3 receptor antagonists and an antihistamine in haemodialysis patients","volume":"13","author":"Weisshaar","year":"2004","journal-title":"Exp Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2025.06.035_bib75","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1365-4632.2010.04537.x","article-title":"Systematic review of topical capsaicin in the treatment of pruritus","volume":"49","author":"Gooding","year":"2010","journal-title":"Int J Dermatol"},{"issue":"3 Pt 1","key":"10.1016\/j.jaad.2025.06.035_bib76","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jaad.2004.08.050","article-title":"Lack of efficacy of tacrolimus ointment 0.1% for treatment of hemodialysis-related pruritus: a randomized, double-blind, vehicle-controlled study","volume":"52","author":"Duque","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.06.035_bib77","article-title":"Treatment of renal pruritus with dupilumab monotherapy: a case report","volume":"12","author":"Glockler-Lauf","year":"2024","journal-title":"SAGE Open Med Case Rep"},{"issue":"4","key":"10.1016\/j.jaad.2025.06.035_bib78","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jdcr.2019.01.024","article-title":"A successful case of dupilumab treatment for severe uremic pruritus","volume":"5","author":"Silverberg","year":"2019","journal-title":"JAAD Case Rep"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.035_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010968","article-title":"Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy","volume":"5","author":"St\u00e4nder","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.035_bib80","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/toxins14030197","article-title":"The serum level of IL-31 in patients with chronic kidney disease-associated pruritus: what can we expect?","volume":"14","author":"\u015awierczy\u0144ska","year":"2022","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.jaad.2025.06.035_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155369","article-title":"Elevated interleukin 31 serum levels in hemodialysis patients are associated with uremic pruritus","volume":"138","author":"Oweis","year":"2021","journal-title":"Cytokine"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.035_bib82","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jaad.2014.08.004","article-title":"Interleukin-31 is associated with uremic pruritus in patients receiving hemodialysis","volume":"71","author":"Ko","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2025.06.035_bib83","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/jdv.13643","article-title":"Cutaneuos findings in patients with predialysis chronic kidney disease","volume":"30","author":"Solak","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.035_bib84","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4103\/0378-6323.25636","article-title":"Cutaneous manifestations in patients with chronic renal failure on hemodialysis","volume":"72","author":"Udayakumar","year":"2006","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jaad.2025.06.035_bib85","doi-asserted-by":"crossref","DOI":"10.5402\/2012\/679619","article-title":"Cutaneous manifestations in patients with chronic kidney disease on maintenance hemodialysis","volume":"2012","author":"Kolla","year":"2012","journal-title":"ISRN Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2025.06.035_bib86","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1093\/ndt\/10.12.2269","article-title":"Dry skin (xerosis) in patients undergoing maintenance haemodialysis: the role of decreased sweating of the eccrine sweat gland","volume":"10","author":"Park","year":"1995","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"10.1016\/j.jaad.2025.06.035_bib87","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2133.1995.tb02705.x","article-title":"Sweat secretion, stratum corneum hydration, small nerve function and pruritus in patients with advanced chronic renal failure","volume":"133","author":"Yosipovitch","year":"1995","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2025.06.035_bib88","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1093\/ndt\/gfm375","article-title":"Skin barrier structure and function and their relationship to pruritus in end-stage renal disease","volume":"22","author":"Yosipovitch","year":"2007","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.035_bib89","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/jdv.18608","article-title":"Acquired ichthyosis, asteatotic dermatitis or xerosis? An update on pathoetiology and drug-induced associations","volume":"37","author":"Park","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"10.1016\/j.jaad.2025.06.035_bib90","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/1346-8138.15950","article-title":"Efficacy of a moisturizer for pruritus accompanied by xerosis in patients undergoing dialysis: a multicenter, open-label, randomized verification study","volume":"48","author":"Yoshida","year":"2021","journal-title":"J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.035_bib91","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4103\/2229-5178.105458","article-title":"Clinicoepidemiological study of skin manifestations in patients of chronic renal failure on hemodialysis","volume":"4","author":"Deshmukh","year":"2013","journal-title":"Indian Dermatol Online J"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.035_bib92","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4103\/idoj.IDOJ_160_17","article-title":"Mucocutaneous manifestations in patients with chronic kidney disease: a cross-sectional study","volume":"9","author":"Rashpa","year":"2018","journal-title":"Indian Dermatol Online J"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.035_bib93","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s12325-020-01524-6","article-title":"Burden of anemia in chronic kidney disease: beyond erythropoietin","volume":"38","author":"Hanna","year":"2021","journal-title":"Adv Ther"},{"issue":"21.43","key":"10.1016\/j.jaad.2025.06.035_bib94","first-page":"28","article-title":"Cutaneous manifestations in Egyptian patients with chronic renal failure on regular hemodialysis","volume":"25","author":"Sultan","year":"2009","journal-title":"Dermatitis"},{"issue":"5959","key":"10.1016\/j.jaad.2025.06.035_bib95","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1136\/bmj.1.5959.658","article-title":"Plasma immunoreactive beta-melanocyte-stimulating hormone and skin pigmentation in chronic renal failure","volume":"1","author":"Smith","year":"1975","journal-title":"Br Med J"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.035_bib96","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212237","article-title":"Evaluation of hemostasis in patients with end-stage renal disease","volume":"14","author":"G\u00e4ckler","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.035_bib97","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/ijd.IJD_502_20","article-title":"Cutaneous manifestations of chronic kidney disease, dialysis and post-renal transplant: a review","volume":"66","author":"Goel","year":"2021","journal-title":"Indian J Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2025.06.035_bib98","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/ki.2008.299","article-title":"Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"74","author":"Locatelli","year":"2008","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.035_bib99","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/10600280241241563","article-title":"Daprodustat: a hypoxia-inducible factor-prolyl hydroxylase inhibitor for anemia of chronic kidney disease","volume":"59","author":"Johnson","year":"2024","journal-title":"Ann Pharmacother"},{"issue":"5","key":"10.1016\/j.jaad.2025.06.035_bib100","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/ndt\/gfab065","article-title":"Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial","volume":"37","author":"Singh","year":"2022","journal-title":"Nephrol Dial Transpl"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.035_bib101","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1053\/j.ajkd.2006.04.087","article-title":"Quantitative comparison of skin colors in patients with ESRD undergoing different dialysis modalities","volume":"48","author":"Lai","year":"2006","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.035_bib102","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/ijd.12963","article-title":"Uremic frost: a harbinger of impending renal failure","volume":"55","author":"Saardi","year":"2016","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.035_bib103","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4103\/0971-4065.97127","article-title":"A prospective study of cutaneous abnormalities in patients with chronic kidney disease","volume":"22","author":"Thomas","year":"2012","journal-title":"Indian J Nephrol"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.035_bib104","first-page":"268","article-title":"Skin changes in patients with chronic renal failure","volume":"22","author":"Falodun","year":"2011","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.035_bib105","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/sj.ki.5002587","article-title":"Uremic frost in a critically ill patient","volume":"73","author":"Pol-Rodriguez","year":"2008","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.jaad.2025.06.035_bib106","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/ckj\/sfu057","article-title":"Uremic frost","volume":"7","author":"Mathur","year":"2014","journal-title":"Clin Kidney J"},{"issue":"12","key":"10.1016\/j.jaad.2025.06.035_bib107","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.4065\/83.12.1309","article-title":"Uremic frost","volume":"83","author":"Bhattarai","year":"2008","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"10.1016\/j.jaad.2025.06.035_bib108","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s00134-015-3664-x","article-title":"Uremic frost: a clinical symptom of severe azotemia","volume":"41","author":"Jullien","year":"2015","journal-title":"Intensive Care Med"},{"issue":"9","key":"10.1016\/j.jaad.2025.06.035_bib109","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/qjmed\/hcad091","article-title":"Uremic frost","volume":"116","author":"Ono","year":"2023","journal-title":"QJM"},{"issue":"17","key":"10.1016\/j.jaad.2025.06.035_bib110","doi-asserted-by":"crossref","DOI":"10.1503\/cmaj.091779","article-title":"Uremic frost","volume":"182","author":"Kuo","year":"2010","journal-title":"CMAJ"},{"issue":"11","key":"10.1016\/j.jaad.2025.06.035_bib111","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/ki.2012.70","article-title":"Uremic frost","volume":"81","author":"Mohan","year":"2012","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.jaad.2025.06.035_bib112","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1525-139X.2012.01109.x","article-title":"Diagnosis of common dermopathies in dialysis patients: a review and update","volume":"25","author":"Markova","year":"2012","journal-title":"Semin Dial"},{"key":"10.1016\/j.jaad.2025.06.035_bib113","series-title":"Dermatological Manifestations of Kidney Disease","author":"Nunley","year":"2015"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.035_bib114","first-page":"202","article-title":"Decreased uroporphyrinogen decarboxylase activity in patients with end-stage renal disease undergoing hemodialysis","volume":"70","author":"Mamet","year":"1995","journal-title":"Nephron"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.035_bib115","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/ckj\/sfx146","article-title":"Porphyria and kidney diseases","volume":"11","author":"Pallet","year":"2018","journal-title":"Clin Kidney J"},{"issue":"12","key":"10.1016\/j.jaad.2025.06.035_bib116","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1111\/1346-8138.16948","article-title":"Risk of bullous pemphigoid and pemphigus in patients on chronic dialysis: a nationwide population-based cohort study","volume":"50","author":"Tang","year":"2023","journal-title":"J Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2025.06.035_bib117","first-page":"1480","article-title":"Association between chronic kidney disease and risk of bullous pemphigoid: a nationwide population-based cohort study","volume":"21","author":"Yu","year":"2023","journal-title":"J Dtsch Dermatol Ges"},{"issue":"20","key":"10.1016\/j.jaad.2025.06.035_bib118","doi-asserted-by":"crossref","DOI":"10.1503\/cmaj.180152","article-title":"Porphyria cutanea tarda presenting as milia and blisters","volume":"190","author":"Nguyen","year":"2018","journal-title":"CMAJ"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.035_bib119","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1525-139X.2008.00534.x","article-title":"Dermatologic conditions seen in end-stage renal disease","volume":"22","author":"Cordova","year":"2009","journal-title":"Semin Dial"},{"issue":"8","key":"10.1016\/j.jaad.2025.06.035_bib120","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3390\/diagnostics11081343","article-title":"Laboratory diagnosis of porphyria","volume":"11","author":"Di Pierro","year":"2021","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.035_bib121","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1600-0560.1992.tb01557.x","article-title":"Histologic and immunofluorescence study of cutaneous porphyrias","volume":"19","author":"Maynard","year":"1992","journal-title":"J Cutan Pathol"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.035_bib122","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0190-9622(03)00893-4","article-title":"Pseudoporphyria associated with hemodialysis treated with N-acetylcysteine","volume":"49","author":"Tremblay","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.035_bib123","doi-asserted-by":"crossref","first-page":"538","DOI":"10.2340\/00015555-0156","article-title":"Successful outcome of haemodialysis-induced pseudoporphyria after short-term oral N-acetylcysteine and switch to high-flux technique dialysis","volume":"86","author":"Massone","year":"2006","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.035_bib124","first-page":"64","article-title":"A case of haemodialysis-associated pseudoporphyria successfully treated with oral N-acetylcysteine","volume":"32","author":"Cooke","year":"2007","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.035_bib125","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/ki.2010.442","article-title":"Pseudoporphyria associated with hemodialysis","volume":"79","author":"Felix","year":"2011","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.035_bib126","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1365-2133.2000.03393.x","article-title":"Treatment of haemodialysis-associated pseudoporphyria with N-acetylcysteine: report of two cases","volume":"142","author":"Vadoud-Seyedi","year":"2000","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2025.06.035_bib127","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.cgh.2012.08.038","article-title":"Low-dose hydroxychloroquine is as effective as phlebotomy in treatment of patients with porphyria cutanea tarda","volume":"10","author":"Singal","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaad.2025.06.035_bib128","article-title":"Porphyria cutanea tarda in a patient with end-stage renal disease: a case of successful treatment with deferoxamine and ferric carboxymaltose","volume":"2017","author":"Rodrigues","year":"2017","journal-title":"Case Rep Nephrol"},{"issue":"9","key":"10.1016\/j.jaad.2025.06.035_bib129","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1681\/ASN.V291445","article-title":"Removal of plasma porphyrins with high-flux hemodialysis in porphyria cutanea tarda associated with end-stage renal disease","volume":"2","author":"Carson","year":"1992","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jaad.2025.06.035_bib130","article-title":"Plasma porphyrins among end stage renal disease patients and cutaneous symptoms- is there still an association?","volume":"33","author":"Goldman","year":"2022","journal-title":"Mol Genet Metab Rep"},{"issue":"4","key":"10.1016\/j.jaad.2025.06.035_bib131","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1067\/mjd.2000.105504","article-title":"Management of porphyria cutanea tarda in the setting of chronic renal failure: a case report and review","volume":"42","author":"Shieh","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.035_bib132","first-page":"125","article-title":"Treatment of hemodialysis-related porphyria cutanea tarda with small repeated phlebotomies","volume":"46","author":"Riccioni","year":"1987","journal-title":"Nephron"},{"issue":"5","key":"10.1016\/j.jaad.2025.06.035_bib133","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1365-2133.1986.tb04071.x","article-title":"Iron removal therapy in porphyria cutanea tarda: phlebotomy versus slow subcutaneous desferrioxamine infusion","volume":"114","author":"Rocchi","year":"1986","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2025.06.035_bib134","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/archdermatol.2012.807","article-title":"Deferasirox for porphyria cutanea tarda: a pilot study","volume":"148","author":"Pandya","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2025.06.035_bib135","unstructured":"Werth V. Efficacy and Safety of Dupilumab in Patients with Bullous Pemphigoid: Results From LIBERTY-BP ADEPT. Phase 2\/3 Study. Presented at the 2025 American Academy of Dermatology (AAD) Annual Meeting. Orlando, FL; March 07-11, 2025."},{"key":"10.1016\/j.jaad.2025.06.035_bib136","article-title":"Pemphigoid diseases in patients with end-stage kidney diseases: pathogenesis and treatment","volume":"15","author":"Yang","year":"2024","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.jaad.2025.06.035_bib137","first-page":"825","article-title":"Treatment of acquired reactive perforating dermatosis - a systematic review","volume":"16","author":"Luk\u00e1cs","year":"2018","journal-title":"J Dtsch Dermatol Ges"},{"issue":"7","key":"10.1016\/j.jaad.2025.06.035_bib138","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/jdv.16182","article-title":"The treatment of Kyrle's disease: a systematic review","volume":"34","author":"Forouzandeh","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.035_bib139","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/archderm.1968.01610120023003","article-title":"Kyrle's disease. II. Histopathologic findings in five cases and review of the literature","volume":"97","author":"Constantine","year":"1968","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.035_bib140","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.nefroe.2024.03.006","article-title":"Acquired perforating dermatosis and dermatology life quality index in patients receiving hemodialysis","volume":"44","author":"Roldan-Contreras","year":"2024","journal-title":"Nefrologia (Engl Ed)"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.035_bib141","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/archderm.1982.01650140017009","article-title":"Kyrle's disease in patients with chronic renal failure","volume":"118","author":"Hood","year":"1982","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.035_bib142","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4103\/CDR.CDR_59_18","article-title":"A clinical study of cutaneous manifestations in patients with chronic kidney disease on conservative management, hemodialysis, and renal transplant recipient","volume":"4","author":"Khare","year":"2020","journal-title":"Clin Dermatol Rev"},{"issue":"1021","key":"10.1016\/j.jaad.2025.06.035_bib143","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/pgmj.2009.095745","article-title":"Comparison of cutaneous manifestations in chronic kidney disease with or without dialysis","volume":"86","author":"Khanna","year":"2010","journal-title":"Postgrad Med J"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.035_bib144","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1067\/mjd.2000.110651","article-title":"Cutaneous manifestations of end-stage renal disease","volume":"43","author":"Robinson-Bostom","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.035_bib145","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4103\/ijpm.ijpm_162_23","article-title":"Evaluation of the histopathological spectrum of skin biopsies in patients with chronic kidney disease: a single-center experience","volume":"67","author":"Fathaddin","year":"2024","journal-title":"Indian J Pathol Microbiol"},{"issue":"4","key":"10.1016\/j.jaad.2025.06.035_bib146","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/ijd.14760","article-title":"Acquired perforating dermatosis: clinicopathologic study of a 10-year period at a tertiary teaching hospital","volume":"59","author":"Garrido","year":"2020","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.035_bib147","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1542-4758.2009.00405.x","article-title":"Acquired perforating dermatoses in patients with diabetic kidney disease on hemodialysis","volume":"14","author":"Hari Kumar","year":"2010","journal-title":"Hemodial Int"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.035_bib148","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4103\/1319-2442.391892","article-title":"Acquired perforating dermatosis: a disorder treatable with mycophenolate mofetil","volume":"34","author":"Al-Bader","year":"2023","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.jaad.2025.06.035_bib149","article-title":"Dupilumab improve acquired reactive perforating collagenosis characterized by type 2 inflammation","volume":"14","author":"Liu","year":"2023","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.035_bib150","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/1346-8138.13525","article-title":"Successful treatment of Kyrle disease with narrowband ultraviolet B","volume":"44","author":"Matsuzaki","year":"2017","journal-title":"J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2025.06.035_bib151","doi-asserted-by":"crossref","DOI":"10.1503\/cmaj.091185","article-title":"Acquired reactive perforating collagenosis","volume":"182","author":"Kreuter","year":"2010","journal-title":"CMAJ"},{"issue":"5","key":"10.1016\/j.jaad.2025.06.035_bib152","doi-asserted-by":"crossref","first-page":"530","DOI":"10.2340\/00015555-0685","article-title":"Acquired reactive perforating collagenosis successfully treated with narrow-band ultraviolet B","volume":"89","author":"Mii","year":"2009","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.035_bib153","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jaad.2004.08.018","article-title":"Treatment of acquired perforating dermatosis with narrowband ultraviolet B","volume":"52","author":"Gambichler","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2025.06.035_bib154","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3109\/15569527.2012.657726","article-title":"Cutaneous changes in patients with chronic renal failure on hemodialysis","volume":"31","author":"Onelmis","year":"2012","journal-title":"Cutan Ocul Toxicol"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.035_bib155","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.det.2012.08.002","article-title":"Drugs and hair loss","volume":"31","author":"Patel","year":"2013","journal-title":"Dermatol Clin"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.035_bib156","doi-asserted-by":"crossref","first-page":"415.e1","DOI":"10.1016\/j.jaad.2014.04.070","article-title":"Evaluation and diagnosis of the hair loss patient: Part I. History and clinical examination","volume":"71","author":"Mubki","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.06.035_bib157","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2340\/0001555554137140","article-title":"Skin and nail disorders in relation to chronic renal failure","volume":"54","author":"Kint","year":"1974","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2025.06.035_bib158","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40801-015-0056-z","article-title":"Traditional anticoagulants and hair loss: a role for direct oral anticoagulants? A review of the literature","volume":"3","author":"Watras","year":"2016","journal-title":"Drugs Real World Outcomes"},{"issue":"3","key":"10.1016\/j.jaad.2025.06.035_bib159","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/0190-9622(90)70066-Q","article-title":"Punctate keratoses of the palms and soles and keratotic pits of the palmar creases","volume":"22","author":"Rustad","year":"1990","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2025.06.035_bib160","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/archinte.1967.00290240105007","article-title":"The half-and-half nail","volume":"119","author":"Lindsay","year":"1967","journal-title":"Arch Intern Med"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225023606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225023606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T10:59:39Z","timestamp":1789642779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962225023606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":160,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0190962225023606"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2025.06.035","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Part I: Dermatologic manifestations in patients with kidney disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.06.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.06.034","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}